Eli Lilly (LLY) Construction in Progress (2012 - 2024)

Eli Lilly (LLY) has reported Construction in Progress for 13 consecutive years, with $8.2 billion the latest figure, recorded in Q4 2024.

• Construction in Progress for Q4 2024 came in at $8.2 billion, up 62.17% year-over-year; the trailing twelve-month figure through Dec 2024 was $8.2 billion (up 62.17% YoY), and the FY2024 annual result was $8.2 billion, up 62.17% from the prior year.
• Construction in Progress was $8.2 billion for Q4 2024 at Eli Lilly, up from $5.1 billion in the prior quarter.
• Over five years, Construction in Progress peaked at $8.2 billion in Q4 2024 and troughed at $2.1 billion in Q4 2020.
• Average Construction in Progress over 5 years is $4.1 billion, with a median of $2.8 billion recorded in 2022.
• Year-over-year, Construction in Progress increased 1.82% in 2021 and surged 81.67% in 2023.
• Over 5 years, Construction in Progress stood at $2.1 billion in 2020, then advanced by 1.82% to $2.2 billion in 2021, then increased by 28.51% to $2.8 billion in 2022, then jumped by 81.67% to $5.1 billion in 2023, then soared by 62.17% to $8.2 billion in 2024.
• Per Business Quant data, the three most recent Construction in Progress figures were $8.2 billion in Q4 2024, $5.1 billion in Q4 2023, and $2.8 billion in Q4 2022.